RFP QuestBeta
OpenStage · award

Newcastle University

(NU/1887) Gene Editing iPSC for Haematopoietic Disease Modelling

R&DCPV 73111000
ValueValue not published
Deadline
Published5 Oct 2023
RegionNationwide
Who to contact
Dr Emma Barksby
emma.barksby@ncl.ac.uk
+44 1912086298

The procurement contact named on the official notice.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

The project concerns work described in a Wellcome Trust Investigator Award which requires the differentiation and functional assessment of macrophages from iPSC carrying mutations of clonal haematopoiesis including TET2 frameshift, DNMT3A R882 and BRAF V600E.

Funding in the application is available for a research partner to supply these reagents.

Key requirements

What the supplier must deliver

01

Funding in the application is available

Funding in the application is available for a research partner to supply these reagents.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at Newcastle University, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
ocds-h6vhtk-03aca3
Stage
award · Awarded
Source
Find a Tender
Buyer ref
029453-2023
View the original notice on Find a Tender

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Research & Development

Assembling the market network…

Newcastle University’s tender network

Assembling the network…